European Mistletoe

European mistletoe contains viscotoxins and lectins (ML-I, ML-II) that stimulate immune activity and may induce apoptosis in cancer cells. These compounds activate natural killer cells and enhance immune surveillance. In European integrative oncology, injectable extracts like Iscador are used alongside conventional treatments to improve quality of life, reduce chemotherapy side effects, and potentially slow tumor progression. Evidence Level: C. Research shows promising but mixed results, particularly for symptom management and immune support.

Yes, European mistletoe has clinically significant interactions with immunosuppressant medications. Because mistletoe stimulates immune function, it can counteract drugs prescribed after organ transplants or for autoimmune conditions. Concurrent use with immunosuppressive therapy is contraindicated. Patients on antihypertensive or antidiabetic medications should also exercise caution, as mistletoe may affect blood pressure and glucose levels. Evidence Level: C. Always inform your healthcare provider about all herbal supplements.

Dosage depends on the preparation and purpose. Injectable extracts like Iscador require professional medical supervision and are administered in clinical settings, typically 2-3 times weekly. For traditional tea preparations, 2-4 grams of dried leaves daily is commonly recommended. Self-treatment for serious conditions is not advised. Evidence Level: Traditional. A qualified healthcare practitioner should determine appropriate dosing based on individual health status and treatment goals.

European mistletoe is considered unsafe during pregnancy and breastfeeding. The plant contains compounds that may stimulate uterine contractions, potentially increasing miscarriage risk. Active constituents can pass into breast milk, posing risks to nursing infants. Historical use included mistletoe for fertility support, but modern guidance strongly contraindicates its use during pregnancy. Evidence Level: C. Women who are pregnant, nursing, or trying to conceive should avoid all mistletoe preparations.

European mistletoe has been used traditionally for hypertension, epilepsy, and fertility support. In modern integrative medicine, it is primarily researched and applied in oncology settings as an adjunctive therapy. Injectable extracts are used to support cancer patients by improving quality of life, reducing fatigue, and mitigating chemotherapy side effects. Evidence Level: C. While historical applications are well-documented, current evidence is strongest for integrative oncology use under professional supervision.